Election Result 
MADHYA PRADESH - 230
PartyLW
CONG2112
BJP1108
IND04
OTH03
RAJASTHAN - 199
Party20182013
CONG9921
BJP73163
IND137
OTH149
CHHATTISGARH - 90
PartyLW
CONG167
BJP015
BSP+07
OTH00
TELANGANA - 119
Party20182014
TRS8863
TDP, CONG+2137
AIMIM77
OTH39
MIZORAM - 40
Party20182013
MNF265
IND80
CONG534
OTH10
  • search

Advanced molecular research facility ready by June 2006

Written by: Staff
|

Hyderabad, Apr 24 (UNI) Vimta Labs, a leading quality testing and standardisation organisation, today announced that its new Life Sciences Facility at the S P Biotech Park in Genome Valley on the outskirts here was nearing completion.

As a part of the expansion plans Vimta has initiated setting up of advanced molecular research facility comprising genomics and proteomics. ''This facility is expected to be fully commissioned by the end of this quarter''. It will have customer specific laboratories to meet global outsourcing demands and is shaping up as a world class Research Process Outsourcing (RPO) facility. The facility can employ 1000 scientists.

The company has posted a Gross Revenue of Rs 55.06 crore with EBITDA of Rs 25.78 crores and profit after tax (PAT) of Rs 13.5 crore. ''The year 2006-07 is expected to match the growth rates already experienced by Vimta during 2000 to 2005''.

With the current growth plans in place Vimta's revenues are estimated to be in the range of Rs 90 to Rs 100 crore with EBITDA of 46-50 % and PAT of 23-27%. The envisaged inorganic growth plans on materialisation are likely to supplment revenues. Company's Chairman and Managing Director Dr S P Vasireddy said after a meeting here of the Board of Directors which recommended a 40 % dividend to the shareholders.

UNI DB VV ADB1910

For Daily Alerts

For Breaking News from Oneindia
Get instant news updates throughout the day.

Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more